美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Alto Neuroscience

16.50

-0.2100-1.26%

成交量：1.84万

成交额：30.47万

市值：5.13亿

市盈率：-7.16

高：16.95

开：16.46

低：16.33

收：16.71

52周最高：20.91

52周最低：1.60

股本：3,106.63万

流通股本：2,399.34万

量比：0.56

换手率：0.08%

股息：- -

股息率：- -

每股收益(TTM):-2.3058

每股收益(LYR):-2.4970

净资产收益率：-45.01%

总资产收益率：-24.48%

市净率：4.59

市盈率(LYR):-6.61

数据加载中...

总览公司新闻资讯公告

Alto Neuroscience, Inc.盘中异动早盘快速下跌5.07%报16.30美元

Alto Neuroscience, Inc.盘中异动早盘急速上涨5.27%报17.37美元

Alto Neuroscience, Inc.盘中异动股价大涨5.81%

Alto Neuroscience Inc 提交 SEC 备案，拟由股东再售最多 850 万股

Alto Neuroscience, Inc.盘中异动早盘大幅上涨5.07%

Alto Neuroscience：计划于2026年上半年启动Alto-207的2B期临床试验，并于2027年初开展3期试验

Alto Neuroscience Inc：Alto-101在Cias的第二阶段试验初步数据预计2026年第一季度公布，Alto-300在Mdd的试验数据预计2026年中期公布

BUZZ--美国股票走势-亚马逊、Nvidia、MongoDB

Alto Neuroscience, Inc.盘中异动股价大涨5.47%报12.92美元

BUZZ-Alto Neuroscience计划加速抑郁症药物开发，股价随之上涨

Alto Neuroscience 宣布加快 Alto-207 在耐药性抑郁症治疗中的开发计划，因近期 FDA 会议取得成功成果

嗡嗡声--美国股票走势-Spyre Therapeutics、Astria、沃尔玛

嗡嗡声--美国股票走势-西方石油公司 , GameStop, Alphabet

Neonc Technologies Holdings, Inc.盘中异动早盘股价大跌5.70%

Forte Biosciences, Inc.盘中异动早盘股价大涨6.14%

Alto Neuroscience股价盘前大涨12.5%，此前公司精神分裂症药物获得FDA"快速通道"认定

BUZZ-Alto Neuroscience 因精神分裂症药物获得 FDA "快速通道 "标签而攀升

Alto Neuroscience的Alto-101药物获得FDA快速通道资格，用于治疗精神分裂症相关认知障碍

Alto Neuroscience宣布成功复制脑电图生物标志物，可客观识别精神分裂症患者的认知障碍

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ANRO/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ANRO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANRO\",,,,,undefined,":{"symbol":"ANRO","market":"US","secType":"STK","nameCN":"Alto Neuroscience","latestPrice":16.5,"timestamp":1770909172442,"preClose":16.71,"halted":0,"volume":18362,"delay":0,"changeRate":-0.012567324955116747,"floatShares":23993387,"shares":31066335,"eps":-2.305836,"marketStatus":"交易中","change":-0.21,"latestTime":"02-12 10:13:11 EST","open":16.4645,"high":16.95,"low":16.33,"amount":304739.259142,"amplitude":0.037104,"askPrice":16.79,"askSize":341,"bidPrice":16.5,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-2.305836,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770930000000},"marketStatusCode":2,"adr":0,"listingDate":1706850000000,"exchange":"NYSE","adjPreClose":16.71,"postHourTrading":{"tag":"盘后","latestPrice":16.71,"preClose":16.71,"latestTime":"17:16 EST","volume":3864,"amount":64562.03,"timestamp":1770848170445,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.562825,"impliedVol":0.2918,"impliedVolPercentile":0.0637},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANRO\",,,,,undefined,":{"symbol":"ANRO","floatShares":23993387,"roa":"-24.48%","roe":"-45.01%","lyrEps":-2.496992,"volumeRatio":0.562825,"shares":31066335,"dividePrice":0,"high":16.95,"amplitude":0.037104,"preClose":16.71,"low":16.33,"week52Low":1.6,"pbRate":"4.59","week52High":20.9075,"institutionHeld":0,"latestPrice":16.5,"committee":-0.988338,"eps":-2.305836,"divideRate":0,"volume":18362,"delay":0,"ttmEps":-2.305836,"open":16.4645,"prevYearClose":17.8,"prevWeekClose":15.22,"prevMonthClose":15.48,"prevQuarterClose":17.8,"fiveDayClose":14.11,"twentyDayClose":17.16,"sixtyDayClose":12.11},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ANRO\",params:#limit:5,,,undefined,":[{"date":"2026-03-20","symbol":"ANRO","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774036800000,"name":null,"time":"盘后","dateTimestamp":1773979200000,"actualEps":null},{"market":"US","date":"2025-11-12","symbol":"ANRO","fiscalQuarterEnding":"2025/09","expectedEps":-0.66,"name":null,"time":"盘前","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.52},{"market":"US","date":"2025-08-13","symbol":"ANRO","fiscalQuarterEnding":"2025/06","expectedEps":-0.57,"name":null,"time":"盘后","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.65}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ANRO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ANRO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.4,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4,"analysts":10,"updateTime":1763442000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ANRO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ANRO","date":"2026-02-10","current":-7.246829,"percent":0.188912,"low":-16.978804,"twenty":-8.242506,"median":-2.803305,"eighty":-1.315408,"high":-0.793245,"avg":-4.934024,"sd":3.822492,"marketCap":523157081},"quantilePoints":[{"date":"2024-02-09","current":-15.481605,"twenty":-16.048587,"median":-15.481605,"eighty":-13.872658,"marketCap":506867732},{"date":"2024-02-16","current":-12.96931,"twenty":-15.548491,"median":-13.234406,"eighty":-11.571235,"marketCap":424615224},{"date":"2024-02-23","current":-10.603839,"twenty":-15.481605,"median":-12.585941,"eighty":-11.026361,"marketCap":347169680},{"date":"2024-03-01","current":-12.56147,"twenty":-14.292343,"median":-12.488059,"eighty":-11.135662,"marketCap":411262544},{"date":"2024-03-08","current":-11.631595,"twenty":-13.230328,"median":-12.361629,"eighty":-11.293904,"marketCap":380818433},{"date":"2024-03-15","current":-12.153631,"twenty":-13.001937,"median":-12.137317,"eighty":-11.306955,"marketCap":397909864},{"date":"2024-03-22","current":-11.14409,"twenty":-12.949734,"median":-12.108768,"eighty":-11.306955,"marketCap":404586204},{"date":"2024-03-28","current":-12.415912,"twenty":-12.956259,"median":-12.145474,"eighty":-11.437463,"marketCap":450759680},{"date":"2024-04-05","current":-10.418119,"twenty":-12.920369,"median":-11.868143,"eighty":-11.162905,"marketCap":378229815},{"date":"2024-04-12","current":-10.440317,"twenty":-12.863272,"median":-11.793418,"eighty":-10.823597,"marketCap":379035702},{"date":"2024-04-19","current":-9.988964,"twenty":-12.713187,"median":-11.631595,"eighty":-10.532067,"marketCap":362649325},{"date":"2024-04-26","current":-10.455115,"twenty":-12.538631,"median":-11.566341,"eighty":-10.461035,"marketCap":379572960},{"date":"2024-05-03","current":-10.654895,"twenty":-12.497847,"median":-11.513206,"eighty":-10.478793,"marketCap":386825947},{"date":"2024-05-10","current":-10.802879,"twenty":-12.4592,"median":-11.360121,"eighty":-10.478793,"marketCap":392198529},{"date":"2024-05-17","current":-8.114957,"twenty":-12.377436,"median":-11.191128,"eighty":-10.431438,"marketCap":344382544},{"date":"2024-05-24","current":-7.443985,"twenty":-12.295701,"median":-11.079356,"eighty":-10.270134,"marketCap":315907856},{"date":"2024-05-31","current":-7.59948,"twenty":-12.254775,"median":-10.943138,"eighty":-9.999323,"marketCap":322506720},{"date":"2024-06-07","current":-7.453823,"twenty":-12.218885,"median":-10.773282,"eighty":-9.088414,"marketCap":316325341},{"date":"2024-06-14","current":-7.612146,"twenty":-12.153631,"median":-10.654895,"eighty":-8.114957,"marketCap":323044231},{"date":"2024-06-21","current":-6.997854,"twenty":-12.14058,"median":-10.580902,"eighty":-7.890353,"marketCap":296974938},{"date":"2024-06-28","current":-6.731872,"twenty":-12.125897,"median":-10.558705,"eighty":-7.854905,"marketCap":285687202},{"date":"2024-07-05","current":-7.35883,"twenty":-12.080219,"median":-10.514309,"eighty":-7.738804,"marketCap":312294007},{"date":"2024-07-12","current":-8.486086,"twenty":-11.912764,"median":-10.492111,"eighty":-7.738804,"marketCap":360132504},{"date":"2024-07-15","current":-8.840728,"twenty":-11.90384,"median":-10.492111,"eighty":-7.738804,"marketCap":375182817},{"date":"2024-08-02","current":-6.212575,"twenty":-11.894916,"median":-10.481012,"eighty":-7.674208,"marketCap":263649243},{"date":"2024-08-09","current":-5.762939,"twenty":-11.86488,"median":-10.440317,"eighty":-7.584281,"marketCap":244567596},{"date":"2024-08-16","current":-5.077305,"twenty":-11.842621,"median":-10.421819,"eighty":-7.439715,"marketCap":252875166},{"date":"2024-08-23","current":-5.770157,"twenty":-11.798049,"median":-10.270134,"eighty":-7.320833,"marketCap":287382652},{"date":"2024-08-30","current":-6.766131,"twenty":-11.747422,"median":-10.066655,"eighty":-7.023186,"marketCap":336987162},{"date":"2024-09-06","current":-6.885215,"twenty":-11.696849,"median":-9.985264,"eighty":-6.997854,"marketCap":342918136},{"date":"2024-09-13","current":-7.036776,"twenty":-11.629964,"median":-9.589405,"eighty":-7.005638,"marketCap":350466649},{"date":"2024-09-20","current":-7.269531,"twenty":-11.615282,"median":-8.800669,"eighty":-7.041657,"marketCap":362059007},{"date":"2024-09-27","current":-6.495486,"twenty":-11.576129,"median":-8.327763,"eighty":-6.997854,"marketCap":323507676},{"date":"2024-10-04","current":-5.51575,"twenty":-11.542663,"median":-8.073812,"eighty":-6.792939,"marketCap":274711934},{"date":"2024-10-11","current":-6.392641,"twenty":-11.505807,"median":-7.947789,"eighty":-6.506312,"marketCap":318385471},{"date":"2024-10-18","current":-7.724215,"twenty":-11.453451,"median":-7.863613,"eighty":-6.586066,"marketCap":384704544},{"date":"2024-10-25","current":-2.23553,"twenty":-11.361501,"median":-7.821648,"eighty":-6.506312,"marketCap":111340558},{"date":"2024-10-31","current":-2.181401,"twenty":-11.357822,"median":-7.776801,"eighty":-6.403467,"marketCap":108644661},{"date":"2024-11-08","current":-2.083968,"twenty":-11.223755,"median":-7.738804,"eighty":-6.212575,"marketCap":103792046},{"date":"2024-11-15","current":-2.159604,"twenty":-11.191128,"median":-7.724215,"eighty":-6.11117,"marketCap":124062772},{"date":"2024-11-22","current":-1.92017,"twenty":-11.14409,"median":-7.634377,"eighty":-5.98126,"marketCap":110307987},{"date":"2024-11-29","current":-2.070403,"twenty":-11.113816,"median":-7.615312,"eighty":-5.768005,"marketCap":118938440},{"date":"2024-12-06","current":-1.830969,"twenty":-11.06322,"median":-7.574148,"eighty":-5.648645,"marketCap":105183655},{"date":"2024-12-13","current":-1.798105,"twenty":-11.000259,"median":-7.504253,"eighty":-5.44863,"marketCap":103295743},{"date":"2024-12-20","current":-1.746462,"twenty":-10.916697,"median":-7.443985,"eighty":-5.07514,"marketCap":100329024},{"date":"2024-12-27","current":-2.075098,"twenty":-10.841355,"median":-7.436869,"eighty":-2.363274,"marketCap":119208142},{"date":"2025-01-03","current":-2.056319,"twenty":-10.79104,"median":-7.390494,"eighty":-2.255016,"marketCap":118129335},{"date":"2025-01-10","current":-2.070403,"twenty":-10.767363,"median":-7.35883,"eighty":-2.165554,"marketCap":118938440},{"date":"2025-01-17","current":-2.079793,"twenty":-10.725927,"median":-7.312287,"eighty":-2.141345,"marketCap":119477844},{"date":"2025-01-24","current":-2.272279,"twenty":-10.654895,"median":-7.277651,"eighty":-2.138097,"marketCap":130535613},{"date":"2025-01-31","current":-2.093877,"twenty":-10.603839,"median":-7.253293,"eighty":-2.122046,"marketCap":120286949},{"date":"2025-02-07","current":-1.854443,"twenty":-10.580902,"median":-7.17813,"eighty":-2.093877,"marketCap":106532163},{"date":"2025-02-14","current":-1.530502,"twenty":-10.558705,"median":-7.145034,"eighty":-2.075098,"marketCap":87922747},{"date":"2025-02-21","current":-1.464775,"twenty":-10.529107,"median":-7.061183,"eighty":-2.070403,"marketCap":84146924},{"date":"2025-02-28","current":-1.305152,"twenty":-10.515789,"median":-6.997854,"eighty":-2.041295,"marketCap":74977067},{"date":"2025-03-07","current":-1.854443,"twenty":-10.50839,"median":-6.933931,"eighty":-2.023455,"marketCap":106532163},{"date":"2025-03-14","current":-1.483554,"twenty":-10.495071,"median":-6.768,"eighty":-2.01289,"marketCap":85225730},{"date":"2025-03-21","current":-1.180996,"twenty":-10.492111,"median":-6.549615,"eighty":-1.993408,"marketCap":72549751},{"date":"2025-03-28","current":-1.062067,"twenty":-10.474353,"median":-6.422411,"eighty":-1.971812,"marketCap":65243830},{"date":"2025-04-04","current":-0.81528,"twenty":-10.458075,"median":-6.392641,"eighty":-1.92017,"marketCap":50083438},{"date":"2025-04-11","current":-0.903418,"twenty":-10.443277,"median":-6.253891,"eighty":-1.873222,"marketCap":55497864},{"date":"2025-04-17","current":-0.991556,"twenty":-10.440317,"median":-6.19297,"eighty":-1.833785,"marketCap":60912290},{"date":"2025-04-25","current":-1.004777,"twenty":-10.431438,"median":-6.11117,"eighty":-1.798105,"marketCap":61724454},{"date":"2025-05-02","current":-1.079695,"twenty":-10.421079,"median":-6.037568,"eighty":-1.742706,"marketCap":66326716},{"date":"2025-05-09","current":-0.965115,"twenty":-10.40924,"median":-5.975847,"eighty":-1.645994,"marketCap":59287962},{"date":"2025-05-16","current":-1.041186,"twenty":-10.323409,"median":-5.766106,"eighty":-1.583083,"marketCap":65785273},{"date":"2025-05-23","current":-1.255422,"twenty":-10.270134,"median":-5.686944,"eighty":-1.500455,"marketCap":79321337},{"date":"2025-05-30","current":-1.152589,"twenty":-10.199102,"median":-5.617282,"eighty":-1.480737,"marketCap":72824027},{"date":"2025-06-06","current":-1.019763,"twenty":-10.071835,"median":-5.469741,"eighty":-1.461958,"marketCap":64431667},{"date":"2025-06-13","current":-1.049756,"twenty":-10.02004,"median":-5.30697,"eighty":-1.408438,"marketCap":66326716},{"date":"2025-06-20","current":-0.972631,"twenty":-9.987484,"median":-5.077305,"eighty":-1.322054,"marketCap":61453732},{"date":"2025-06-27","current":-0.985485,"twenty":-9.980084,"median":-2.492642,"eighty":-1.263991,"marketCap":62265896},{"date":"2025-07-03","current":-1.006909,"twenty":-9.974165,"median":-2.341082,"eighty":-1.221144,"marketCap":63619503},{"date":"2025-07-11","current":-1.105457,"twenty":-9.589405,"median":-2.272279,"eighty":-1.163435,"marketCap":69846092},{"date":"2025-07-18","current":-1.233999,"twenty":-8.963166,"median":-2.213594,"eighty":-1.13545,"marketCap":77967731},{"date":"2025-07-25","current":-1.319693,"twenty":-8.840728,"median":-2.178383,"eighty":-1.148304,"marketCap":83382157},{"date":"2025-08-01","current":-1.315408,"twenty":-8.760609,"median":-2.161951,"eighty":-1.152589,"marketCap":83111436},{"date":"2025-08-08","current":-1.311123,"twenty":-8.486086,"median":-2.154336,"eighty":-1.163435,"marketCap":82840714},{"date":"2025-08-15","current":-1.302504,"twenty":-8.327763,"median":-2.124393,"eighty":-1.163435,"marketCap":84479082},{"date":"2025-08-22","current":-1.498714,"twenty":-8.182106,"median":-2.122046,"eighty":-1.165443,"marketCap":97205098},{"date":"2025-08-29","current":-1.590557,"twenty":-8.114957,"median":-2.098572,"eighty":-1.169728,"marketCap":103161956},{"date":"2025-09-05","current":-1.465317,"twenty":-8.049126,"median":-2.084227,"eighty":-1.178742,"marketCap":95038967},{"date":"2025-09-12","current":-1.640654,"twenty":-7.979964,"median":-2.075098,"eighty":-1.18912,"marketCap":106411151},{"date":"2025-09-19","current":-1.715798,"twenty":-7.951589,"median":-2.070403,"eighty":-1.198007,"marketCap":111284945},{"date":"2025-09-26","current":-1.586383,"twenty":-7.904286,"median":-2.056319,"eighty":-1.216859,"marketCap":102891190},{"date":"2025-10-03","current":-1.841039,"twenty":-7.881184,"median":-2.039887,"eighty":-1.228,"marketCap":119407933},{"date":"2025-10-10","current":-2.513164,"twenty":-7.867586,"median":-2.056319,"eighty":-1.233142,"marketCap":163001306},{"date":"2025-10-17","current":-2.454718,"twenty":-7.85227,"median":-2.070403,"eighty":-1.244282,"marketCap":159210578},{"date":"2025-10-24","current":-4.667305,"twenty":-7.827138,"median":-2.075098,"eighty":-1.253708,"marketCap":302716712},{"date":"2025-10-31","current":-5.978158,"twenty":-7.812987,"median":-2.084227,"eighty":-1.2897,"marketCap":387737327},{"date":"2025-11-07","current":-4.646431,"twenty":-7.783605,"median":-2.103267,"eighty":-1.301657,"marketCap":301362880},{"date":"2025-11-14","current":-4.738274,"twenty":-7.773873,"median":-2.122046,"eighty":-1.304622,"marketCap":307319739},{"date":"2025-11-21","current":-7.060871,"twenty":-7.758215,"median":-2.12674,"eighty":-1.306199,"marketCap":439588640},{"date":"2025-11-28","current":-6.91117,"twenty":-7.745076,"median":-2.154336,"eighty":-1.306688,"marketCap":430268739},{"date":"2025-12-05","current":-6.67664,"twenty":-7.738804,"median":-2.161951,"eighty":-1.306839,"marketCap":415667562},{"date":"2025-12-12","current":-7.325342,"twenty":-7.736546,"median":-2.178383,"eighty":-1.309247,"marketCap":456053797},{"date":"2025-12-19","current":-9.705579,"twenty":-7.761946,"median":-2.213594,"eighty":-1.311015,"marketCap":604240215},{"date":"2025-12-26","current":-9.920149,"twenty":-7.817318,"median":-2.253904,"eighty":-1.311123,"marketCap":617598739},{"date":"2026-01-02","current":-8.882226,"twenty":-7.875492,"median":-2.303191,"eighty":-1.311123,"marketCap":552980763},{"date":"2026-01-09","current":-7.929133,"twenty":-7.944058,"median":-2.354526,"eighty":-1.311807,"marketCap":493644063},{"date":"2026-01-16","current":-8.493005,"twenty":-8.098499,"median":-2.410079,"eighty":-1.314542,"marketCap":528749021},{"date":"2026-01-23","current":-8.572845,"twenty":-8.233524,"median":-2.467243,"eighty":-1.314542,"marketCap":533719635},{"date":"2026-01-30","current":-7.644703,"twenty":-8.248494,"median":-2.550736,"eighty":-1.315408,"marketCap":475936252},{"date":"2026-02-06","current":-7.040911,"twenty":-8.233524,"median":-2.675047,"eighty":-1.315408,"marketCap":438345986},{"date":"2026-02-10","current":-8.403185,"twenty":-8.242506,"median":-2.803305,"eighty":-1.315408,"marketCap":523157081}],"updateTime":1770887763796},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ANRO\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2605297811","title":"Alto Neuroscience, Inc.盘中异动 早盘快速下跌5.07%报16.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605297811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605297811?lang=zh_cn&edition=fundamental","pubTime":"2026-01-20 22:35","pubTimestamp":1768919724,"startTime":"0","endTime":"0","summary":"北京时间2026年01月20日22时35分，Alto Neuroscience, Inc.股票出现波动，股价大幅跳水5.07%。Alto Neuroscience, Inc.股票所在的生物技术行业中，整体跌幅为1.46%。Alto Neuroscience, Inc.公司简介：Alto Neuroscience Inc 是一家临床阶段的生物制药公司，其使命是通过利用个人的神经生物学来开发个性化和有效的治疗方案，重新定义精神病学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120223524a73109b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120223524a73109b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ANRO"],"gpt_icon":0},{"id":"2603983145","title":"Alto Neuroscience, Inc.盘中异动 早盘急速上涨5.27%报17.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603983145","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603983145?lang=zh_cn&edition=fundamental","pubTime":"2026-01-14 23:39","pubTimestamp":1768405150,"startTime":"0","endTime":"0","summary":"北京时间2026年01月14日23时39分，Alto Neuroscience, Inc.股票出现异动，股价急速拉升5.27%。截至发稿，该股报17.37美元/股，成交量3.625万股，换手率0.12%，振幅7.45%。Alto Neuroscience, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Alto Neuroscience, Inc.公司简介：Alto Neuroscience Inc 是一家临床阶段的生物制药公司，其使命是通过利用个人的神经生物学来开发个性化和有效的治疗方案，重新定义精神病学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114233910953ccab4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114233910953ccab4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANRO","BK4007"],"gpt_icon":0},{"id":"2592072116","title":"Alto Neuroscience, Inc.盘中异动 股价大涨5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592072116","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592072116?lang=zh_cn&edition=fundamental","pubTime":"2025-12-19 22:32","pubTimestamp":1766154745,"startTime":"0","endTime":"0","summary":"北京时间2025年12月19日22时32分，Alto Neuroscience, Inc.股票出现异动，股价大幅上涨5.81%。Alto Neuroscience, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。Alto Neuroscience, Inc.公司简介：Alto Neuroscience Inc 是一家临床阶段的生物制药公司，其使命是通过利用个人的神经生物学来开发个性化和有效的治疗方案，重新定义精神病学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121922322597a07f37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121922322597a07f37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ANRO"],"gpt_icon":0},{"id":"1114455067","title":"Alto Neuroscience Inc 提交 SEC 备案，拟由股东再售最多 850 万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1114455067","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114455067?lang=zh_cn&edition=fundamental","pubTime":"2025-11-28 19:03","pubTimestamp":1764327791,"startTime":"0","endTime":"0","summary":"Alto Neuroscience Inc 提交 SEC 备案，拟由股东再售最多 850 万股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANRO","BK4007"],"gpt_icon":0},{"id":"2584995166","title":"Alto Neuroscience, Inc.盘中异动 早盘大幅上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584995166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584995166?lang=zh_cn&edition=fundamental","pubTime":"2025-11-19 00:10","pubTimestamp":1763482236,"startTime":"0","endTime":"0","summary":"北京时间2025年11月19日00时10分，Alto Neuroscience, Inc.股票出现波动，股价大幅拉升5.07%。Alto Neuroscience, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。Alto Neuroscience, Inc.公司简介：Alto Neuroscience Inc 是一家临床阶段的生物制药公司，其使命是通过利用个人的神经生物学来开发个性化和有效的治疗方案，重新定义精神病学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119001037a7024d5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119001037a7024d5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ANRO"],"gpt_icon":0},{"id":"1126170894","title":"Alto Neuroscience：计划于2026年上半年启动Alto-207的2B期临床试验，并于2027年初开展3期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1126170894","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126170894?lang=zh_cn&edition=fundamental","pubTime":"2025-11-12 21:01","pubTimestamp":1762952462,"startTime":"0","endTime":"0","summary":"Alto Neuroscience：计划于2026年上半年启动Alto-207的2B期临床试验，并于2027年初开展3期试验","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANRO","BK4007"],"gpt_icon":0},{"id":"1159041976","title":"Alto Neuroscience Inc：Alto-101在Cias的第二阶段试验初步数据预计2026年第一季度公布，Alto-300在Mdd的试验数据预计2026年中期公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1159041976","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159041976?lang=zh_cn&edition=fundamental","pubTime":"2025-11-12 20:58","pubTimestamp":1762952292,"startTime":"0","endTime":"0","summary":"Alto Neuroscience Inc：Alto-101在Cias的第二阶段试验初步数据预计2026年第一季度公布，Alto-300在Mdd的试验数据预计2026年中期公布","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANRO","BK4007"],"gpt_icon":0},{"id":"2580141210","title":"BUZZ--美国股票走势-亚马逊、Nvidia、MongoDB","url":"https://stock-news.laohu8.com/highlight/detail?id=2580141210","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580141210?lang=zh_cn&edition=fundamental","pubTime":"2025-11-04 00:06","pubTimestamp":1762185962,"startTime":"0","endTime":"0","summary":"nL6N3WF0IQ ** Nvidia Corp NVDA.O:BUZZ - 因美国允许微软在阿联酋出口该公司的人工智能芯片而上涨   nL4N3WF0SZ ** Alexander's Inc ALX.N:BUZZ - 因第三季度利润下滑而下跌  nL4N3WF13A ** MongoDB Inc MDB.O:BUZZ - 因软件公司预计第三季度业绩高于预期、任命新首席执行官而上涨。nL4N3WF13G ** Alvotech SA ALVO.O:BUZZ - 因美国FDA拒绝批准关节炎药物而下跌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nL4S3WF16W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDXX","ANRO","KMB","ALK","CHTR","MD","QURE","ALVO","NVIW.SI","USAW.SI","NVDS.UK","CAT","ETN","PHIO","EBS","NVDD","AMZN","GLLI","NVD3.UK","MSPR","MTSR","CIVI","TOST","SNVD.UK","KVUE","SO","SM","NVD","IMAX","VNO","NVD2.UK","ON","TERN","CMS","MDB","NVDA","TGE","ALX","FRPT"],"gpt_icon":1},{"id":"2579106926","title":"Alto Neuroscience, Inc.盘中异动 股价大涨5.47%报12.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579106926","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579106926?lang=zh_cn&edition=fundamental","pubTime":"2025-10-29 01:29","pubTimestamp":1761672546,"startTime":"0","endTime":"0","summary":"北京时间2025年10月29日01时29分，Alto Neuroscience, Inc.股票出现异动，股价快速上涨5.47%。截至发稿，该股报12.92美元/股，成交量44.0772万股，换手率1.43%，振幅9.02%。Alto Neuroscience, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Alto Neuroscience, Inc.公司简介：Alto Neuroscience Inc 是一家临床阶段的生物制药公司，其使命是通过利用个人的神经生物学来开发个性化和有效的治疗方案，重新定义精神病学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251029012906a47a34ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251029012906a47a34ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANRO","BK4007"],"gpt_icon":0},{"id":"2576851163","title":"BUZZ-Alto Neuroscience计划加速抑郁症药物开发，股价随之上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2576851163","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576851163?lang=zh_cn&edition=fundamental","pubTime":"2025-10-20 20:26","pubTimestamp":1760963165,"startTime":"0","endTime":"0","summary":"BUZZ-Alto Neuroscience计划加速抑郁症药物开发，股价随之上涨10月20日 - ** 药物开发商Alto NeuroscienceANRO.N股价盘前上涨8.2%至6.58美元** 公司表示计划加速开发针对耐药性抑郁症患者的实验性药物ALTO-207 ** 耐药性抑郁症是一种重度抑郁症，患者在尝试了至少两种不同的抗抑郁药物并服用足够剂量和足够时间后，症状仍未得到改善。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nL4T3W10E3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANRO"],"gpt_icon":0},{"id":"1189774850","title":"Alto Neuroscience 宣布加快 Alto-207 在耐药性抑郁症治疗中的开发计划，因近期 FDA 会议取得成功成果","url":"https://stock-news.laohu8.com/highlight/detail?id=1189774850","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189774850?lang=zh_cn&edition=fundamental","pubTime":"2025-10-20 19:01","pubTimestamp":1760958069,"startTime":"0","endTime":"0","summary":"Alto Neuroscience 宣布加快 Alto-207 在耐药性抑郁症治疗中的开发计划，因近期 FDA 会议取得成功成果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANRO"],"gpt_icon":0},{"id":"2575217706","title":"嗡嗡声--美国股票走势-Spyre Therapeutics、Astria、沃尔玛","url":"https://stock-news.laohu8.com/highlight/detail?id=2575217706","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575217706?lang=zh_cn&edition=fundamental","pubTime":"2025-10-14 23:55","pubTimestamp":1760457357,"startTime":"0","endTime":"0","summary":"nL3N3VV0MP ** Spyre Therapeutics Inc SYRE.O:BUZZ - 募集 2.75 亿美元股本后股价上涨   nL6N3VV0QB ** CNX Resources Corp link) >：** EQT Corp EQT.N：** Energy Transfer LP ET.N：** NextDecade Corp link) >：BUZZ - 天然气公司因天气温和、需求预测减弱而下跌   nL3N3VV1BA ** 惠普公司HPQ.N：BUZZ--汇丰银行将惠普的评级提升至 \"买入\"，原因是个人电脑销售势头改善。nL6N3VV0PD ** Astria Therapeutics Inc ATXS.O:BUZZ - 因BioCryst达成7亿美元收购交易而大涨   nL3N3VV18T ** Fastenal Co FAST.O:BUZZ - 巴克莱下调Fastenal第三季度利润预期，低于预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nL3T3VV1G7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PII","HUM","ACI","PCH","CNX","ET","SYRE","2NVD.UK","EDHL","RYN","GM","SNTI","BLK","JNJ","PMAX","PTRN","DE","CVX","BCRX","ANET","DPZ","OEC","XOM","APA","NVAX","GWAV","PAVS","3NVD.UK","HPQ","EQT","FAST","NVIW.SI","MGM","AQMS","AKA","WMT","ATXS","ANRO","DLTR","WAB","NEXT","EXPD"],"gpt_icon":1},{"id":"2572686686","title":"嗡嗡声--美国股票走势-西方石油公司 , GameStop, Alphabet","url":"https://stock-news.laohu8.com/highlight/detail?id=2572686686","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572686686?lang=zh_cn&edition=fundamental","pubTime":"2025-10-03 23:10","pubTimestamp":1759504227,"startTime":"0","endTime":"0","summary":"美国东部时间10:28，道琼斯工业平均指数.DJI上涨0.79%，报46,889.01点；标准普尔500指数.SPX上涨0.32%，报6,736.59点；纳斯达克综合指数.IXIC上涨0.03%，报22,851.38点。标准普尔500指数.PG.INX涨幅前三名是。** Centene Corp CNC.N，上涨 4.4标准普尔 500 指数.PL.INX百分比跌幅前三名：。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251003:nL3T3VK0UO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OVID","LU1582986359.USD","RBLX","EPSM","ALK","LU2756315664.SGD","AREB","SBUX","CNC","CSW","DUK","BK4130","GME","HUM","AMAT","LU0198837287.USD","BK4555","ANRO","LU","FOUR","BHP.AU","GOOGL","TSYW.SI","TECK","LU2360107671.USD","NNNN","SCCO","LU0994945656.USD","SES","MSGY","OXY","LU0310800965.SGD","RCKT","LVS","BGSF","ASNS","ALGN","CART","MACW.SI","VSCO","WYNN","SG9999001424.SGD","ESPR"],"gpt_icon":1},{"id":"2572687188","title":"Neonc Technologies Holdings, Inc.盘中异动 早盘股价大跌5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572687188","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572687188?lang=zh_cn&edition=fundamental","pubTime":"2025-10-03 23:04","pubTimestamp":1759503896,"startTime":"0","endTime":"0","summary":"北京时间2025年10月03日23时04分，Neonc Technologies Holdings, Inc.股票出现异动，股价快速下挫5.70%。Neonc Technologies Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。Neonc Technologies Holdings, Inc.公司简介：NeOnc Technologies Holdings Inc是一种新型分子技术的开发商，该技术为治疗中枢神经系统疾病提供了增强的靶向递送技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100323045794b9e1b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100323045794b9e1b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NTHI","BK4007","ANRO"],"gpt_icon":0},{"id":"2572997688","title":"Forte Biosciences, Inc.盘中异动 早盘股价大涨6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572997688","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572997688?lang=zh_cn&edition=fundamental","pubTime":"2025-10-03 21:37","pubTimestamp":1759498654,"startTime":"0","endTime":"0","summary":"北京时间2025年10月03日21时37分，Forte Biosciences, Inc.股票出现异动，股价快速上涨6.14%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃和1型糖尿病等适应症方面具有广泛的自身免疫应用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003213734971e7860&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003213734971e7860&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBRX","BK4007","ANRO","BK4139"],"gpt_icon":0},{"id":"1125127493","title":"Alto Neuroscience股价盘前大涨12.5%，此前公司精神分裂症药物获得FDA\"快速通道\"认定","url":"https://stock-news.laohu8.com/highlight/detail?id=1125127493","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125127493?lang=zh_cn&edition=fundamental","pubTime":"2025-10-03 20:00","pubTimestamp":1759492819,"startTime":"0","endTime":"0","summary":"Alto Neuroscience股价在盘前交易中大幅上涨12.5%，此前该公司宣布其精神分裂症治疗药物获得了美国食品药品监督管理局(FDA)的\"快速通道\"认定。这一认定将有助于加速该药物的审批进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANRO"],"gpt_icon":0},{"id":"2572502879","title":"BUZZ-Alto Neuroscience 因精神分裂症药物获得 FDA \"快速通道 \"标签而攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2572502879","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572502879?lang=zh_cn&edition=fundamental","pubTime":"2025-10-03 19:54","pubTimestamp":1759492492,"startTime":"0","endTime":"0","summary":"BUZZ-Alto Neuroscience 因精神分裂症药物获得 FDA \"快速通道 \"标签而攀升10月3日 - ** 药物开发商Alto Neuroscience ANRO.N的股价盘前上涨10%至4.93美元** 该公司称其实验性药物ALTO-101获得了美国FDA的 \"快速通道 \"认证，有助于改善精神分裂症患者的思维和记忆能力。** 美国食品和药物管理局的 \"快速通道 \"标签旨在加快开发和审查用于治疗未满足医疗需求的严重疾病的药物。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251003:nL3S3VK0NH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANRO"],"gpt_icon":0},{"id":"1122358594","title":"Alto Neuroscience的Alto-101药物获得FDA快速通道资格，用于治疗精神分裂症相关认知障碍","url":"https://stock-news.laohu8.com/highlight/detail?id=1122358594","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122358594?lang=zh_cn&edition=fundamental","pubTime":"2025-10-03 19:35","pubTimestamp":1759491317,"startTime":"0","endTime":"0","summary":"Alto Neuroscience的Alto-101药物获得FDA快速通道资格，用于治疗精神分裂症相关认知障碍。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANRO"],"gpt_icon":0},{"id":"1120768292","title":"Alto Neuroscience宣布成功复制脑电图生物标志物，可客观识别精神分裂症患者的认知障碍","url":"https://stock-news.laohu8.com/highlight/detail?id=1120768292","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120768292?lang=zh_cn&edition=fundamental","pubTime":"2025-09-09 19:09","pubTimestamp":1757416181,"startTime":"0","endTime":"0","summary":"Alto Neuroscience宣布成功复制脑电图生物标志物，可客观识别精神分裂症患者的认知障碍","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANRO"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}]}}